特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
938724

感染症検査の世界市場:2025年までの予測と市場機会

Global Infectious Disease Testing Market By Product & Service, By Technology, By Disease, By End User, By Region, Forecast & Opportunities, 2025

出版日: | 発行: TechSci Research | ページ情報: 英文 112 Pages | 納期: お問合せ

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

感染症検査の世界市場:2025年までの予測と市場機会
出版日: 2020年05月01日
発行: TechSci Research
ページ情報: 英文 112 Pages
納期: お問合せ
  • 全表示
  • 概要
  • 目次
概要

世界の感染症検査市場は、予測期間中に大きなCAGRで成長すると予想されます。 世界の感染症検査市場は、世界中で感染症を抱える人口の増加によって牽引されています。さらに、世界中の政府による医療インフラストラクチャへの投資は、予測期間中の市場の成長を後押しすると予想されます。また、 医療セクターにおける研究開発活動の増加により、今後数年間で市場の成長がさらに強化されると予想されます。

当レポートは、世界の感染症検査市場をセグメント別や地域別で調査したもので、市場規模および市場シェアの予測、促進要因と課題、市場動向、競合情勢、企業プロファイルなどの情報を提供しています。

目次

第1章 製品の概要

第2章 調査手法

第3章 世界の感染症検査市場に対するCOVID-19の影響

第4章 エグゼクティブサマリー

第5章 顧客の声

第6章 世界の感染症検査市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • 製品およびサービス別(アッセイ、キット、および試薬、機器、サービスおよびソフトウェア)
    • 技術別(免疫診断、臨床微生物学、ポリメラーゼ連鎖反応(PCR)、等温核酸増幅技術(INAAT)、DNAシーケンス&次世代シーケンス(NGS)、DNAマイクロアレイ、その他)
    • 疾患別(肝炎、HIV、HAIS、HPV、TB、インフルエンザ、腺熱、コロナウイルス、その他)
    • エンドユーザー別(病院/臨床検査室、参照検査室、医師のオフィス、学術/ 調査機関、その他)
    • 会社別
    • 地域別
  • 市場魅力指数

第7章 アジア太平洋の感染症検査市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • 製品およびサービス別
    • 技術別
    • 疾患別
    • エンドユーザー別
    • 国別
    • 競合の展望
  • アジア太平洋:国分析
    • 中国
    • インド
    • オーストラリア
    • 日本
    • 韓国
    • インドネシア
    • シンガポール
    • マレーシア

第8章 欧州の感染症検査市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • 製品およびサービス別
    • 技術別
    • 疾患別
    • エンドユーザー別
    • 国別
    • 競合の展望
  • 欧州:国分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • トルコ

第9章 北米の感染症検査市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • 製品およびサービス別
    • 技術別
    • 疾患別
    • エンドユーザー別
    • 国別
    • 競合の展望
  • 北米:国分析
    • 米国
    • メキシコ
    • カナダ

第10章 南米の感染症検査市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • 製品およびサービス別
    • 技術別
    • 疾患別
    • エンドユーザー別
    • 国別
    • 競合の展望
  • 南米:国分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第11章 中東・アフリカの感染症検査市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • 製品およびサービス別
    • 技術別
    • 疾患別
    • エンドユーザー別
    • 国別
    • 競合の展望
  • 中東・アフリカ:国分析
    • 南アフリカ
    • サウジアラビア
    • UAE
    • エジプト
    • ナイジェリア

第12章 市場力学

  • 促進要因
  • 課題

第13章 市場動向と発展

第14章 特許分析

第15章 競合情勢

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Biomerieux SA
  • Bio-Rad Laboratories
  • Danaher Corporation
  • Diasorin
  • Luminex
  • Meridian Bioscience
  • Quidel
  • Roche Diagnostics
  • Siemens AG
  • Thermo Fisher Scientific
  • Johnson and Johnson
  • F. Hoffmann-La Roche Ltd
  • Cepheid

第16章 戦略的推奨事項

第17章 免責事項

目次
Product Code: 4695

Global infectious disease testing market is expected to grow at a significant CAGR during the forecast period. The global infectious disease testing market is driven by rising populace having infectious diseases across the globe. Moreover, investments in healthcare infrastructure by governments across the globe is expected to fuel the growth of market during the forecast period. Also, increase in research and developmental activities in the healthcare sector is further expected to bolster the growth of market over the next few years.

The global infectious disease testing market is segmented based on product and service, technology, disease, end user, company, and region. Based on product and service, the market can be categorized into assays, kits, & reagents; instruments; services & software. Out of which, the assays, kits, & reagents segment dominated the market in terms of largest market share during the forecast period and is expected to maintain its leading position the market during the forecast period as well. This can be ascribed to ease of accessibility coupled with rising number of IDD tests that are being conducted. In addition to this, the volume of IDD tests is growing primarily because of increasing geriatric population along with rising incidence of infectious diseases. Moreover, ongoing development of newer, faster, and more reliable products is further anticipated to boost the growth of segment over the coming years. Along with that, the reagents are available in variety, which is further aiding the market growth.

Major players operating in the global infectious disease testing market include Abbott Laboratories, Becton, Dickinson and Company, Biomerieux SA, Bio-Rad Laboratories, Danaher Corporation, Diasorin, Luminex, Meridian Bioscience, Quidel, Roche Diagnostics, Siemens AG, Thermo Fisher Scientific, Johnson and Johnson, F. Hoffmann-La Roche Ltd, Cepheid, and others. The companies are developing advanced technologies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions, partnership, agreements, and new developments.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study:

  • To analyze and estimate the market size of global infectious disease testing market from 2015 to 2018.
  • To estimate and forecast the market size of global infectious disease testing market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast global infectious disease testing market based on product and service, technology, disease, end user, company and regional distribution.
  • To identify dominant region or segment in the global infectious disease testing market.
  • To identify drivers and challenges for global infectious disease testing market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global infectious disease testing market.
  • To conduct pricing analysis for global infectious disease testing market.
  • To identify and analyze the profile of leading players operating in global infectious disease testing market.
  • To identify key sustainable strategies adopted by market players in global infectious disease testing market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals/clinics across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the hospitals/clinics and presence of all major players across the globe.

TechSci Research calculated the market size of global infectious disease testing market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Infectious disease testing hospitals/clinics, laboratories and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to infectious disease testing
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals/clinics, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global infectious disease testing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Infectious Disease Testing Market, By Product and Service:

Assays, Kits, & Reagents

Instruments

Services & Software

  • Global Infectious Disease Testing Market, By Technology:

Immunodiagnostics

Clinical Microbiology

Polymerase Chain Reaction

Isothermal Nucleic Acid Amplification Technology

DNA Sequencing & Next-Generation Sequencing

DNA Microarray

Other Technologies

  • Global Infectious Disease Testing Market, By Disease:

Hepatitis

HIV

HAIS

HPV

TB

Influenza

Glandular fever

Coronavirus

Others

  • Global Infectious Disease Testing Market, By End User:

Hospital/Clinical Laboratories

Reference Laboratories

Physician Offices

Academic/Research Institutes

Other

  • Global Infectious Disease Testing Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Netherland
  • Russia
  • Turkey

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Singapore
  • Indonesia
  • Malaysia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global infectious disease testing market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Infectious Disease Testing Market

4. Executive Summary

5. Voice of Customer

6. Global Infectious Disease Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product & Service (Assays, Kits, & Reagents; Instruments; Services & Software)
    • 6.2.2. By Technology (Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), DNA Sequencing & Next-Generation Sequencing (NGS), DNA Microarray, Other Technologies)
    • 6.2.3. By Disease (Hepatitis, HIV, HAIS, HPV, TB, Influenza, Glandular fever, Coronavirus, Others)
    • 6.2.4. By End User (Hospital/Clinical Laboratories, Reference Laboratories, Physician Offices, Academic/Research Institutes, Other)
    • 6.2.5. By Company (2019)
    • 6.2.6. By Region
  • 6.3. Market Attractiveness Index

7. Asia-Pacific Infectious Disease Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product and Service
    • 7.2.2. By Technology
    • 7.2.3. By Disease
    • 7.2.4. By End User
    • 7.2.5. By Country
    • 7.2.6. Competition Outlook
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China Infectious Disease Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product and Service
        • 7.3.1.2.2. By Technology
        • 7.3.1.2.3. By Disease
        • 7.3.1.2.4. By End User
    • 7.3.2. India Infectious Disease Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product and Service
        • 7.3.2.2.2. By Technology
        • 7.3.2.2.3. By Disease
        • 7.3.2.2.4. By End User
    • 7.3.3. Australia Infectious Disease Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product and Service
        • 7.3.3.2.2. By Technology
        • 7.3.3.2.3. By Disease
        • 7.3.3.2.4. By End User
    • 7.3.4. Japan Infectious Disease Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product and Service
        • 7.3.4.2.2. By Technology
        • 7.3.4.2.3. By Disease
        • 7.3.4.2.4. By End User
    • 7.3.5. South Korea Infectious Disease Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product and Service
        • 7.3.5.2.2. By Technology
        • 7.3.5.2.3. By Disease
        • 7.3.5.2.4. By End User
    • 7.3.6. Indonesia Infectious Disease Testing Market Outlook
      • 7.3.6.1. Market Size & Forecast
        • 7.3.6.1.1. By Value
      • 7.3.6.2. Market Share & Forecast
        • 7.3.6.2.1. By Product and Service
        • 7.3.6.2.2. By Technology
        • 7.3.6.2.3. By Disease
        • 7.3.6.2.4. By End User
    • 7.3.7. Singapore Infectious Disease Testing Market Outlook
      • 7.3.7.1. Market Size & Forecast
        • 7.3.7.1.1. By Value
      • 7.3.7.2. Market Share & Forecast
        • 7.3.7.2.1. By Product and Service
        • 7.3.7.2.2. By Technology
        • 7.3.7.2.3. By Disease
        • 7.3.7.2.4. By End User
    • 7.3.8. Malaysia Infectious Disease Testing Market Outlook
      • 7.3.8.1. Market Size & Forecast
        • 7.3.8.1.1. By Value
      • 7.3.8.2. Market Share & Forecast
        • 7.3.8.2.1. By Product and Service
        • 7.3.8.2.2. By Technology
        • 7.3.8.2.3. By Disease
        • 7.3.8.2.4. By End User

8. Europe Infectious Disease Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product and Service
    • 8.2.2. By Technology
    • 8.2.3. By Disease
    • 8.2.4. By End User
    • 8.2.5. By Country
    • 8.2.6. Competition Outlook
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Infectious Disease Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product and Service
        • 8.3.1.2.2. By Technology
        • 8.3.1.2.3. By Disease
        • 8.3.1.2.4. By End User
    • 8.3.2. Germany Infectious Disease Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product and Service
        • 8.3.2.2.2. By Technology
        • 8.3.2.2.3. By Disease
        • 8.3.2.2.4. By End User
    • 8.3.3. United Kingdom Infectious Disease Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product and Service
        • 8.3.3.2.2. By Technology
        • 8.3.3.2.3. By Disease
        • 8.3.3.2.4. By End Use
    • 8.3.4. Italy Infectious Disease Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product and Service
        • 8.3.4.2.2. By Technology
        • 8.3.4.2.3. By Disease
        • 8.3.4.2.4. By End User
    • 8.3.5. Spain Infectious Disease Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product and Service
        • 8.3.5.2.2. By Technology
        • 8.3.5.2.3. By Disease
        • 8.3.5.2.4. By End User
    • 8.3.6. Netherland Infectious Disease Testing Market Outlook
      • 8.3.6.1. Market Size & Forecast
        • 8.3.6.1.1. By Value
      • 8.3.6.2. Market Share & Forecast
        • 8.3.6.2.1. By Product and Service
        • 8.3.6.2.2. By Technology
        • 8.3.6.2.3. By Disease
        • 8.3.6.2.4. By End User
    • 8.3.7. Russia Infectious Disease Testing Market Outlook
      • 8.3.7.1. Market Size & Forecast
        • 8.3.7.1.1. By Value
      • 8.3.7.2. Market Share & Forecast
        • 8.3.7.2.1. By Product and Service
        • 8.3.7.2.2. By Technology
        • 8.3.7.2.3. By Disease
        • 8.3.7.2.4. By End User
    • 8.3.8. Turkey Infectious Disease Testing Market Outlook
      • 8.3.8.1. Market Size & Forecast
        • 8.3.8.1.1. By Value
      • 8.3.8.2. Market Share & Forecast
        • 8.3.8.2.1. By Product and Service
        • 8.3.8.2.2. By Technology
        • 8.3.8.2.3. By Disease
        • 8.3.8.2.4. By End User

9. North America Infectious Disease Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product and Service
    • 9.2.2. By Technology
    • 9.2.3. By Disease
    • 9.2.4. By End User
    • 9.2.5. By Country
    • 9.2.6. Competition Outlook
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Infectious Disease Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product and Service
        • 9.3.1.2.2. By Technology
        • 9.3.1.2.3. By Disease
        • 9.3.1.2.4. By End User
    • 9.3.2. Mexico Infectious Disease Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product and Service
        • 9.3.2.2.2. By Technology
        • 9.3.2.2.3. By Disease
        • 9.3.2.2.4. By End User
    • 9.3.3. Canada Infectious Disease Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product and Service
        • 9.3.3.2.2. By Technology
        • 9.3.3.2.3. By Disease
        • 9.3.3.2.4. By End User

10. South America Infectious Disease Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product and Service
    • 10.2.2. By Technology
    • 10.2.3. By Disease
    • 10.2.4. By End User
    • 10.2.5. By Country
    • 10.2.6. Competition Outlook
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Infectious Disease Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product and Service
        • 10.3.1.2.2. By Technology
        • 10.3.1.2.3. By Disease
        • 10.3.1.2.4. By End User
    • 10.3.2. Argentina Infectious Disease Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product and Service
        • 10.3.2.2.2. By Technology
        • 10.3.2.2.3. By Disease
        • 10.3.2.2.4. By End User
    • 10.3.3. Colombia Infectious Disease Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product and Service
        • 10.3.3.2.2. By Technology
        • 10.3.3.2.3. By Disease
        • 10.3.3.2.4. By End Use

11. Middle East and Africa Infectious Disease Testing Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product and Service
    • 11.2.2. By Technology
    • 11.2.3. By Disease
    • 11.2.4. By End User
    • 11.2.5. By Country
    • 11.2.6. Competition Outlook
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Infectious Disease Testing Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product and Service
        • 11.3.1.2.2. By Technology
        • 11.3.1.2.3. By Disease
        • 11.3.1.2.4. By End User
    • 11.3.2. Saudi Arabia Infectious Disease Testing Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product and Service
        • 11.3.2.2.2. By Technology
        • 11.3.2.2.3. By Disease
        • 11.3.2.2.4. By End User
    • 11.3.3. UAE Infectious Disease Testing Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product and Service
        • 11.3.3.2.2. By Technology
        • 11.3.3.2.3. By Disease
        • 11.3.3.2.4. By End User
    • 11.3.4. Egypt Infectious Disease Testing Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Product and Service
        • 11.3.4.2.2. By Technology
        • 11.3.4.2.3. By Disease
        • 11.3.4.2.4. By End User
    • 11.3.5. Nigeria Infectious Disease Testing Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Product and Service
        • 11.3.5.2.2. By Technology
        • 11.3.5.2.3. By Disease
        • 11.3.5.2.4. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Patent Analysis

15. Competitive Landscape

  • 15.1. Abbott Laboratories
  • 15.2. Becton, Dickinson and Company
  • 15.3. Biomerieux SA
  • 15.4. Bio-Rad Laboratories
  • 15.5. Danaher Corporation
  • 15.6. Diasorin
  • 15.7. Luminex
  • 15.8. Meridian Bioscience
  • 15.9. Quidel
  • 15.10. Roche Diagnostics
  • 15.11. Siemens AG
  • 15.12. Thermo Fisher Scientific
  • 15.13. Johnson and Johnson
  • 15.14. F. Hoffmann-La Roche Ltd
  • 15.15. Cepheid

16. Strategic Recommendations

17. About Us & Disclaimer

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.